VeriMomdihydromyricetin hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment raising reproductive concerns were identified. PubMed literature on dihydromyricetin (ampelopsin) focuses on antioxidant, hepatoprotective and metabolic effects; I found no convincing animal or human reproductive toxicity or teratogenicity data. Topical cosmetic absorption is expected to be low but measurable for a small polar flavonoid, so exposure is scored as low (evidence sources: PubMed, PubChem, CosIng, ECHA Annex VI absence).
Related ingredients
Frequently asked questions
- dihydromyricetin hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment raising reproductive concerns were identified. PubMed literature on dihydromyricetin (ampelopsin) focuses on antioxidant, hepatoprotective and metabolic effects; I found no convincing animal or human reproductive toxicity or teratogenicity data. Topical cosmetic absorption is expected to be low but measurable for a small polar flavonoid, so exposure is scored as low (evidence sources: PubMed, PubChem, CosIng, ECHA Annex VI absence).
- dihydromyricetin emzirirken güvenli mi?
- No data indicating reproductive or lactation-specific toxicity or harmonised classifications. No demonstrated mechanism for transfer into milk; systemic exposure from topical use is likely low but measurable, so breastfeeding exposure is scored low (PubMed, PubChem, CosIng; no CIR/SCCS flags).
- dihydromyricetin bebek cildi için güvenli mi?
- No infant-specific toxicity or developmental skin studies were identified. Hazard and mechanistic scores remain 0 due to absence of reproductive/endocrine evidence. Because infant skin has higher permeability and surface-area-to-weight, exposure is increased by +1 versus adult (adult e=1 → infant e=2) for measurable-absorption ingredients (sources: PubMed, CosIng, EWG; no harmonised CLP or SCCS/CIR restrictions).
- VeriMom dihydromyricetin nasıl puanlıyor?
- VeriMom dihydromyricetin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte dihydromyricetin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.